JAK Inhibitors in RA: Applying Evidence-Based Strategies in Clinical Decision-making

Experts discuss the evidence-based application of recent efficacy and safety data for JAK inhibitors in RA to equip healthcare professionals in helping patients attain low disease activity/remission and improved quality of life.

Stanley B. Cohen, MD Janet Pope, MD, MPH, FRCPC Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: January 10, 2023 Expired: No longer available for credit